BRUKER CORP (BRKR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BRKR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BRKR | Chief Executive Officer | 61 | ["Chief Executive Officer of QIAGEN since March 2020","Member of QIAGEN's Managing Board since 2021","Held roles of increasing responsibility during 15 years with bioMérieux SA","Corporate Vice President, Global Commercial Operations, Investor Relations in the Greater China Region","Senior management roles in several leading international companies","Earned degrees and certifications from Sciences Po Paris, the London School of Economics, the College of Europe, Harvard Business School, and Centro de Comercio Exterior de Barcelona","Appointed Conseiller du Commerce Extérieur by the French government"] | ["AdvaMedDx Board of Directors"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NEOG | Director; Chief Executive Officer | 60 | ["Logistics", "Global Sourcing", "Operations", "Executive Leadership", "Mergers & Acquisitions", "Sales & Marketing", "Regulatory", "International"] | ["Compensation", "Governance"] | 2025 |
Biography sourced from the proxy statement filing.
Thierry Bernard has been the Chief Executive Officer of QIAGEN since March 2020 and a member of QIAGEN's Managing Board since 2021. Previously, Mr. Bernard held roles of increasing responsibility during 15 years with bioM rieux SA, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations in the Greater China Region, and held senior management roles in several other leading international companies. He is a member of the AdvaMedDx Board of Directors, a U.S. industry trade association, and in 2024 joined the Board of Directors of Neogen Corporation (NASDAQ: NEOG). Mr. Bernard has earned degrees and certifications from Sciences Po Paris, the London School of Economics, the College of Europe, Harvard Business School, and Centro de Comercio Exterior de Barcelona. He has been appointed Conseiller du Commerce Ext rieur by the French government.